TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
Clinical trial NCT03856099 · TERMINATED
Trial details
- NCT number
- NCT03856099
- Sponsor
- PharmAbcine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-13
- Primary completion
- 2022-07-15
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.